Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age | Neuropsychopharmacology
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
A Practical Approach for the Management of the Mixed Opioid Agonist- Antagonist Buprenorphine During Acute Pain and Surgery - Mayo Clinic Proceedings
Opioid agonists, mixed agonist-antagonists and partial agonists | Osmosis
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study - ScienceDirect
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Opioids to Treat Depression: The Jury Is Out
κ-opioid receptor - Wikipedia
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
Selective kappa opioid antagonists for treatment of addiction, are we there yet? - ScienceDirect
κ-opioid receptor - Wikipedia
Medications Used in Opioid Maintenance Treatment
Kappa receptor (KOR) function in neurocircuits of addiction. This... | Download Scientific Diagram
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists | HTML
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
